Clinical trial
Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda
NCT00405821 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00405821 |
|---|---|
| Title | Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Trial of Acyclovir Prophylaxis Versus Placebo Among HIV-1/HSV-2 Co-Infected Individuals in Uganda |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | University of Washington Johns Hopkins University Translational Genomics Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Herpes Genitalis |
| Intervention type | Drug |
| Interventions | Acyclovir, Placebo |
| Enrollment | 440 |
| Start date | Nov 1, 2006 |
| Primary completion | Oct 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Nov 30, 2006 |
| Last update posted | Sep 28, 2012 |
| Countries | Uganda |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: